Annual Report & Accounts 2018

Improving Transforming Growing

Always improving productivity, transforming our business through our people and growing our market leading positions

Download Annual Report
Highlights of the year
Group operating profit $147.5m +14%
Profit before tax $138.8m +17%
Ashfield operating profit $98.4m +21%
Sharp operating profit $45.8m +11%
Proposed dividend 16.00c +20%
Diluted earnings/share (EPS) 45.94c +24%
Net operating margin 13.1% +49bps

What We Do

UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries.

A global leader in healthcare advisory, communications, commercial and clinical services



Healthcare advisory, strategic consulting, analytics and benchmarking audit services.


Scientific and creative communications, digital and patientcentred content, specialised agencies in behavioural science, rare disease, PR and on-demand advertising services.

Commercial & Clinical

Commercialisation and clinical services including sales representatives, patient services, contact centres, medical affairs and meetings and events.

% of Group operating profit


Net operating margin




A global leader in contract clinical, manufacturing, packaging and technology services



A comprehensive and integrated clinical trial supply and management service, from pre-clinical through to commercialisation.


Clinical manufacturing services including analytical services, formulation development, over-encapsulation and placebo manufacture.


Commercial packaging solutions in multiple formats including bottles, blisters, specialty and secondary packaging of injectables.


Technology to support both commercial and clinical packaging services including design, serialisation solutions and clinical IRT.

% of Group operating profit


Net operating margin




Chairman's Statement A year of further strategic progress with strong growth Read Chairman’s Statement
Our Mission

To improve the lives of patients around the world by partnering with pharmaceutical clients and healthcare providers

Our Strategy Shaping a platform for strategic growth Read Our Strategy
Chief Executive's Review Delivering through a coherent, consistent strategy Read Chief Executive's Review
Our Business Model Our business model revolves around continuously improving our core businesses and identifying and acquiring strong businesses that complement and add value Read Our Business Model
Market Overview Transforming our business to capitalise on the growth in the global healthcare market Read Market Overview